EU vaccine approval ‘too slow’: Austrian chancellor
Austrian Chancellor Sebastian Kurz on Monday criticised the EU’s medicine regulator for being “too slow” in approving coronavirus vaccines as he outlined plans to co-ordinate more closely with Israel on future inoculations.
ustrian Chancellor Sebastian Kurz on Monday criticised the EU’s medicine regulator for being “too slow” in approving coronavirus vaccines as he outlined plans to co-ordinate more closely with Israel on future inoculations.
Kurz said that while the EU’s common procurement and licensing policy for vaccines was “right in principle”, the European Medicines Agency (EMA) “is too slow in approving vaccines and there have been supply bottlenecks at manufacturers”.
He said in a statement that in order to prepare for possible mutations of Covid-19 and to develop “second generation” vaccines, “we should not be solely dependent on the EU anymore”.
To that end Kurz is travelling to Israel on Thursday together with his Danish counterpart Mette Frederiksen to agree a plan for common production of future vaccines and co-operation on research treatments.
Kurz said that experts estimate “that in the coming years we will have to vaccinate two-thirds of the population every year — that’s more than six million Austrians”.
For her part Frederiksen said the world was “crying out” for increased vaccine production but that “we also have to make sure that we have enough vaccines in a year’s time, and in two, three, five and 10 years”.
“One of the partners I have a lot of faith in is Israel, which is currently ahead in the field of vaccination,” she told the Ritzau press agency.
head of the trip to Israel Kurz is to discuss the country’s vaccination strategy with domestic pharmaceutical companies and researchers.
The president of Austria’s association of vaccine manufacturers Renee Gallo-Daniel defended the EMA’s handling of the approval process.
“The highest priority of the EMA has been not to make any shortcuts in the process of approval,” she said.
“The important thing is that the safety, efficacy and quality of all vaccines we are supplied with is checked, and this simply takes time,” she told Oe1 public radio, adding that the EMA had introduced a new “rolling review” process to speed up approval.
She praised Kurz’s “innovative” suggestion of more domestic vaccine production, but cautioned that setting up a vaccine production chain can take “five to 10 years”.
Only 7.8 percent of the Danish population and 4.8 percent of Austria’s population have received a first vaccination dose, while Israel’s figure is over 50 percent.
ustria’s neighbours Slovakia, Hungary and the Czech Republic have bypassed the EMA in order to issue their own approvals for Russian and Chinese coronavirus vaccines.
spokesman for the European Commission reiterated on Friday its position that as long as individual countries didn’t “undermine” EU-level negotiations already underway with certain vaccine providers, “there is nothing in the vaccine strategy that will prevent member states from having discussions or talks or contracts with… (other) vaccine developers”.